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Abstract 
To determine the subcellnlar distribution of PKC after GFs treatment we have employed a combined immunochemical and in situ confocal 
microscopy analysis. In quiescent Swiss 3T3 cells only a faint PKC positivity was observable in the nucleus while a strong reaction was seen in the 
cytoplasm. IGF-I and to a lesser extent PDGF and EGF induced, after 45 rain of treatment, a nuclear translocation of PKC detected by a 
pan-anti-PKC antibody and nuclear fluorescence was distributed in the nuclear interior except for the nucleolar regions. Bombesin and FGF did 
not affect he sub-cellnlar distribution of the enzyme. To further the understanding of which PKC isoform was involved in the translocation process, 
we have tested nine isozyme-specific anti-PKC antibodies. Immunoblotting analysis revealed the presence in Swiss 3T3 fibroblasts of ct, fli, e and 
~" isoforms. In isolated nuclei from GF-exposed cells only the ¢z isozyme was detected: immunostainlng was very intense after IGF-I treatment and 
clearly observable after PDGF and EGF stimulation. This result was strongly supported by the in situ confocal microscopy which parallels the 
Western blot analysis. These data demonstrate hat several, but not all, GFs acting through tyrosine kinase receptor induce the intranuclear 
translocation of PKC t, and, because of the dramatic effect of IGF-I, strengthen the case for a link between the activation of nuclear inositol ipid 
cycle and PKC translocation i duced by this GF. 
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1. Introduction 
In mammalian cells, polypeptide factors trigger the 
generation of signals leading to cell growth and differen- 
tiation. Several GF receptors possess a protein tyrosine 
kinase activity, which acts as an on-off switch, inducing 
a phosphorylative cascade in the cytoplasm [1]. This 
phosphorylative cascade reaches the nucleus and while 
many nuclear proteins appear to be targets, the mecha- 
nism(s) responsible for the activation of DNA synthesis 
remain obscure [2,3]. Recently an entirely separate nu- 
clear phosphoinositide signalling system has been dem- 
onstrated in Swiss 3T3 cells which is under the control 
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serum albumin; PLC, phospholipase C specific for inositol lipid; DAG, 
diacylglycerol; PBS, phosphate-buffered saline; TRITC, tetrameth- 
ylrhodamine isothiocyanate. 
of IGF-I receptor whose stimulation i creases the activ- 
ity of PLC fl and the production of DAG [4-6]. In the 
same time frame, exposure of resting Swiss 3T3 cells to 
IGF-I induces translocation ofPKC to the nucleus [5,6]. 
Therefore, it seems likely that nuclear DAG production 
is responsible for the translocation of PKC from the 
cytoplasm to the nucleus. However, it is still unclear 
whether this translocation is limited to the nuclear enve- 
lope or whether it is truly within the nucleus [5,7], not 
withstanding a number of reports which propose a nu- 
clear localisation of PKC upon treatment with different 
agonists [8-10]. To solve such an issue we have employed 
confocal aser scanning microscopy to examine the in- 
tracellular distribution of PKC in Swiss 3T3 fibroblasts 
treated with different growth factors that are known to 
be physiological inducers of proliferation in 3T3 cells. 
We demonstrate that some but not all of these agonists, 
acting through receptors with an intrinsic tyrosine kinase 
activity, determine translocation of PKC within the nu- 
cleus. To identify which PKC isoform was involved in 
this phenomenon, we have employed nine isozyme-spe- 
cific anti-PKC antibodies. The immunochemical analysis 
indicates that among the four PKC isozymes expressed 
in whole 3T3 cells, only the isoform ~ is selectively 
translocated to the nucleus after GFs treatment. 
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2. Materials and methods 
2.1. Source of materials, immunochemicals and purified PKC 
All tissue culture reagents were f om Sigma Chemical Co. (St. Louis, 
MO). All growth factors were from Boehi'inger (Mannheim, Germany). 
Anti-f tubulin antibody reacting with the f-Lc and f-so fragments in 
the carboxy-terminus of f  tubulin [11] was obtained from Sigma. Both 
the production and characterisation of the pan-anti-PKC serum raised 
against a synthetic peptide of the C-terminal sequence of PKC have 
been essentially described in details by Martelli et al. [12] and a data 
base search using the above synthetic peptide indicates that the se- 
quence shows 100% sequence homology to PKC ct, 93% to PKC t~, 89% 
to PKC y and 60% to PKC fix. The affinity purified antibodies against 
PKC isoforms ~t, fi, fin, 7, ~, e, r/, ~" and 0 were purchased from Santa 
Cruz Biotechnology, (Santa Cruz CA, USA) and used at a concentra- 
tion of 0.25/zg/ml. According to the manufacturer's specifications all 
of the antisera recognise a sequence mapping at or within the carboxy 
terminus of PKC (i.e. a region belonging to the catalytic domain of the 
enzyme). Alkaline phosphatase-coujugated an  TRITC-conjugated 
anti-rabbit IgG were from Sigma. PKC was purified from rat brain as 
previously described y Martelli et al. [13]. 
2.2. Cell culture 
Stock cultures of Swiss 3T3 cells (from Dr. K. Brown laboratory, 
AFRC, Cambridge, UK) responsive to mitogenic stimulation [14] were 
passaged at 3-day intervals in Dulbecco's modified Eagle's medium, 
containing 100 U/ml penicillin, 100/zg/ml streptomycin and 10% foetal 
calf serum, in a humidified 10% CO2 atmosphere. Prior to stimulation, 
cells were subeultured at a density of 104/era 2 nd incubated until they 
became confluent a d quiescent (6--8 days). 
Quiescent cultures of Swiss 3T3 cells were washed twice thserum- 
free medium containing 0.2% BSA and incubated in the same medium 
containing rowth factors as follows: Bombesin (10 nM), IGF-I (20 
ng/ml), PDGF (10 ng/ml), EGF (20 ng/ml), FGF (20 ng/ml). 
2.3. Immunochemical analysis on both intact cells nd isolated nuclei 
Isolated nuclei were prepared exactly as previously reported [6]. It is 
worth recalling that these nuclei have been shown to be free from 
cytoplasmatic contamination bymeans of both biochemical nd mor- 
phological criteria [6]. Moreover, immunochemical analysis with anti-fl 
tubulin monoclonal antibody used at 1 : 500 dilution, reacted with alka- 
line phosphatase-conjugated nti-mouse IgG as secondary antibody 
and detected as detailed below, demonstrated the absence of this cy- 
toskeletal component (see section 3). Swiss 3T3 cells were directly 
dissolved in hot electrophoresis ample buffer and the lysates subse- 
quently were peatedly passaged through a 22-gauge needle to shear 
chromosomal DNA and reduce viscosity. Cell and nuclear proteins 
were separated on 7.5% polyacrylamide/0.1% sodium dodecylsulfate g l 
and blotted to 0.22/an nitrocellulose membrane. Strips containing 
individual lanes were saturated with PBS containing 5% BSA for lh at 
370C and then incubated for 2 h at room temperature with a 1 : 100 
dilution of the pan anti-PKC serum [12] in PBS, 10% normal goat 
serum, 3% BSA or with affinity purified antibodies against the follow- 
ing PKC isoforms: ~, fI, fIl, 7' ~' e, ~, ~ and 0. The membrane strips 
were washed five times with PBS, 0.1% BSA and then incubated for
1 h at room temperature with a 1 : 500 dilution of an alkaline phosphat- 
ase-conjugated anti-rabbit IgG in PBS, 0.1% BSA. After washing as 
above, antibody binding was detected using Nitrotetrazolium blue and 
bromo- chloro-indolyl phosphate as substrates. 
2.4. Detection of PKC by in situ immunofluorescence and confocal 
microscopy 
Cells were washed twice in cold PBS, pH 7.2 and processed for 
indirect immunofluorescence using fixation with freshly made 4% 
paraformaldehyde in PBS (30 rain at room temperature) and permeabil- 
ised with 0.2% Triton X-100 in PBS (10 rain). The pan-anti PKC 
polyclonal ntibody raised against the catalytic region of PKC [12] was 
used at a dilution of 1:25 in 2% BSA, 3% normal goat serum in PBS. 
The secondary antibody was a TRITC-conjugated anti-rabbit IgG di- 
luted 1:80. All incubations were carded out at 37"C. Finally the 
coverslips were mounted in glycerol containing 1,4-diazabicy- 
clo[2.2.2]octane to retard fading, using additional coverslips as spacers 
to preserve the three-dimensional structure of c lls. A variety of con- 
trois was performed to ensure the specificity of the antibody used: 
coverslips were treated with preimmune serum as well as with the 
secondary antibody alone. No fluorescence atall was seen ( ot shown). 
For conventional epifluorescence, specimens were viewed in a Zeiss 
Axiophot photo microscope and photographs were taken on Kodak 
T-Max film. Digital images were taken with a Phoibos 1000-Sarastro 
(Molecular Dynamics) confocal microscope coupled with a Nikon Op- 
tipbot and equipped with an external air cooled argon laser (Spectra 
Physics) emitting in a range of 457-514. The laser was tuned at a power 
output of 10 mV and the laser beam attenuated to 10% with neutral 
density filters. To obtain the highest possible resolution, a 63 × planapo 
oil immersion objective was used (N.A. 1.4). TRITC was excited with 
a 514 nm bandpass and a 530 nm dichroic filter. Emission filter was a 
590/15 nm bandpass. The theoretical optical section thickness was 0.6 
/zm. All images of a given cell were taken with the same photomultiplier 
value in a range of 750-950 V and sequential optical sections were 0.6 
/zm apart in the z axis. On the x-y axis the scanning mode format was 
512 x 512, with a pixel size of 0.2. Digital images processing, quantita- 
tion and display were generated as previously described [15]. 
3. Results 
3.1. Immunochemica l  nalysis 
Nuclear  proteins f rom control  (unstimulated) and 
growth factor-treated (45 rain o f  st imulat ion) cells were 
separated by denatur ing polyacry lamide gel electropho- 
resis, b lotted onto nitrocellulose paper  and probed for 
the presence of  PKC by means o f  a polyclonal  ant ibody 
raised against a synthetic peptide [12] with 100% se- 
quence homology to PKC ~, 93% to PKC ~, 89% to PKC 
7 and 60% to PKC fli- Fig. 1A shows that nuclei f rom 
control  cells and cells treated with Bombesin and FGF  
contained only a very l imited amount  of  protein with a 
Mr of  80 kDa,  comigrat ing with semipurif ied PKC from 
rat brain. On the other hand, nuclei isolated from cells 
exposed to IGF- I ,  PDGF and EGF displayed a higher 
immunoreact iv i ty  for PKC.  However,  the strongest im- 
munochemical  react ion for PKC was by far that  seen in 
nuclei f rom IGF- I - s t imulated cells. The PKC im- 
munoreact iv i ty  d id not  change in lysates obta ined from 
quiescent and agonist-treated cells (Fig. 1B), in which the 
ant ibody also detected a band migrat ing at 50 kDa.  
The 50 kDa protein corresponds to the catalyt ic do- 
main of  PKC.  Indeed, it should be recalled that PKC is 
cleaved by neutral  proteases uch as calpains in the V3 
hinge region to generate two fragments, the regulatory 
and the catalyt ic protein kinase domains,  o f  which the 
latter contains the carboxy terminus o f  the enzyme [2,16]. 
We have previously shown that the pan-PKC ant ibody 
recognisis the catalytic domain  of  the kinase obtained by 
l imited tryptic digestion [13]. Even if isolated nuclei ful- 
filled the biochemical  and morphologica l  criteria of  pu- 
r ity [6], the blotted nuclear proteins f rom control  and 
IGF- I  treated cells, which induce the stronger nuclear 
translocat ion of  PKC,  were also probed for the presence 
of  possible cytoplasmatic ontaminat ion by means of  
anti-fl tubul in ant ibody.  Indeed Fig. I C shows that 
whilst whole cells display a strong immunoreact iv i ty at
55 kDa with the anti-fl tubul in ant ibody, in isolated nu- 
clei fl tubul in is completely absent. 
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The use of isozyme-specific antibodies revealed the 
expression i  Swiss 3T3 cells of only four PKC isoforms: 
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Fig. 2. Immunoblotting analysis by means of anti-PKC isozyme anti- 
bodies of Swiss 3T3 cells and subcellular fractions. Panel (A) whole 
resting cells, pand (B) isolated nuclei. In panel (A) Greek letters refer 
to the various i oforms and the hyphen on the far right lane indicates 
the reaction in the absence of any primary antibody. Panel (B): lanes 
a, b and c refer to nuclei from cells treated with IGF-I, PDGF and EGF, 
~spcctively probed with isozyme-sl~cific anti-PKC-a, -fl~, -e and -~ 
antibodies. For each lane in both (A) and (B) 80 gg of protein was 
loaded. 
Fig. 1. Immunoblotting analysis by means of pan-anti-PKC antibody 
of Swiss 3T3 cells treated with GFs. Panel (A) isolated nuclei, panel (B) 
whole cells. Lane a, control cells; lane b, Bombesin-treated cells; lane 
c, IGF-I-treated cells; lane d, PDGF-treated cells; lane e, EGF-treated 
cells; lane f, FGF-treated cells; lane g, purified PKC from rat brain. 
Panel C shows the immunoblotting analysis with anti-fl tubulin anti- 
body on both purified nuclei and whole cells. Lane a, control whole 
cells; lane b, IGF-I treated whole cells; lane c, nuclei from control cells; 
lane d, nuclei from IGF-I treated cells. For each lane in (A), (B) and 
(C) 80 fig of protein was loaded. In panel (A) arrowhead points to a 
very faint 50 kDa band. 
a, fli, e, ( (Fig. 2A). The position of the immunoreactive 
bands was consistent with the calculated molecular 
weight of these isoforms [2]. The immunochemical anal- 
ysis by means of the above antibodies on nuclei isolated 
from cells treated with the GFs responsible for PKC 
translocation to the nucleus shows that after treatment 
with IGF-I, PDGF or EGF only the a isoform translo- 
cated to the nucleus (Fig. 2B). It should be noted that the 
antibody specific for the ct isoform revealed that nuclear 
fractions contained both the native 80 kDa polypeptide 
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Fig. 3. Confocal laser scanning microscopy optical sections through t e equatorial plane of Swiss 3T3 cells tained with the pan-anti-PKC antibody. 
A, control; B, Bombesin, C FGF; D, IGF-I; E, PDGF; F, EGF. Bar = 5/zm. 
and the 50 kDa proteolytically-cleaved fragment of 
PKC. From the same figure it clearly appears that IGF-I 
induces amassive translocation fthe 0~ isozyme whereas 
after PDGF and EGF treatment this occurs to a lower 
extent. 
At about 80 kDa it is possible to observe a double 
band; this probably reflects different phosphorylation 
states of PKC ~ because this isoform is known to be 
phosphorylated mainly on serine residues which induces 
changes in its electrophoretic mobility [2,17]. Such a dou- 
blet of bands is not detected by the pan-PKC antiserum. 
However, it should be emphasized that the peptide se- 
quences recognised by the two antibodies are different 
(i.e. the sequence of the synthetic peptide for the pan- 
PKC antibody isCYVNPQFVHPILQSAV whereas that 
for the PKC-~ antiserum from Santa Cruz Biotechnol- 
ogy is DFEGFSYVNPQFVHPILQSSV). It might be 
that the latter antiserum can also recognise phos- 
phorylated PKC. These phosphorylative events are cur- 
rently under investigation i our laboratory in order to 
analyse the phosphoaminoacid pattern and their possible 
implications in the regulation of PKC activity. 
3.2. Confocal immunofluorescence and nuclear 
localization 
For the in situ analysis the pan PKC polyclonal anti- 
body raised against he synthetic peptide with 100% se- 
quence homology to PKC ~ was used. The choice was 
suggested because of the high reliability of the antibody 
for immunocytochemistry [12] and because the screening 
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with the isoform-specific antibodies indicated that only 
PKC ~ translocates tothe nucleus. Swiss 3T3 tibroblasts 
were fixed, permeabilised and reacted with the pan-PKC 
polyclonal antibody and finally with TRITC-conjugated 
secondary antibody. 
To rule out the possibility that treatment of the cells 
with GFs modifies PKC distribution in the cytoplasm 
above and below the nucleus, but not within the nucleus, 
an extensive laser scan confocal analysis has been per- 
formed. Optical sections through control cells showed a 
diffuse staining of the cytoplasm very similar to that 
observed with anti-cytoskeleton a tibodies [18] with flu- 
orescent fibres aligned parallel to the long axis of the cells 
and the filamentous network extending throughout the 
cell. In contrast to he strong labelling of the cytoplasm, 
a faint punctate fluorecence of the nuclear region was 
observable (Fig. 3A). Sometimes the edges of the nuclear 
membrane were also stained. The results obtained sug- 
gest that in control cells the antibody identified several 
distinct sites of PKC distribution and these included the 
cytoplasm along with its cytoskeletal component and the 
perinuclear region. Bombesin and FGF treatment did 
not alter the overall distribution of PKC which was de- 
tectable at very low levels within the nucleus (Fig. 3B,C). 
Incubation of cells with IGF-I, PDGF or EGF induced 
changes in the subcellular localisation of PKC as shown 
in Fig. 3 D, E and F, respectively. Exposure to these GFs 
for 45 min. caused a decrease in the cytoplasmic PKC 
levels, while labelling was increased in the nuclear egion. 
However, the redistribution of PKC in Swiss 3T3 fibro- 
blasts treated with these three GFs revealed some differ- 
ences, being strongest in the case of IGF-I-treated cells 
compared with cells incubated in the presence of PDGF 
or EGF (Fig. 3D,E,F). The optical sections allowed us 
to analyse the nuclear interior without out-of-focus blur- 
ring of fluorescence, which unfortunately occurs in con- 
300 
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150 
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0 , 
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Fig. 4. Nuclear fluorescence intensity evaluated by the 'extended focus' 
technique [12]. The values are the average of five separate determina- 
tions +S.D. and are expressed as arbitrary units obtained by an 
image processing that analyses the fluorescence of the three- 
dimensional reconstruction of the whole cell in confocal microscopy. 
ventional fluorescence microscopy. Under these condi- 
tions nucleoli, appearing as black dots in the pictures, are 
unstained in all samples. 
The nuclear fluorescence intensity, evaluated by the 
'extended focus' technique [15], is depicted in Fig. 4, 
which shows that while IGF-I treatment caused a five- 
fold increase in the staining PDGF and EGF caused only 
a three-fold increase. Bombesin and FGF did not signif- 
icantly affect he nuclear fluorescence signal. 
4. Discussion 
The PKC family of isoenzymes i part of a complex 
network of signal transduction pathways involving both 
GTP-binding proteins and growth factor receptor tyro- 
sine kinases (for review see [19]). 
Here we show that GFs acting through receptors with 
intrinsic tyrosine kinase activity, namely IGF-I, PDGF 
and EGF, induce nuclear translocation of PKC 0c, 
whereas Bombesin and FGF, which stimulate pol- 
yphosphoinositide hydrolysis at the plasma membrane 
[19], do not. The nuclear translocation of PKC has been 
shown to occur after treatment with phorbol ester or 
bryostatin [8,10], however the presence of PKC has been 
reported in nuclei of different cells also in the absence of 
a mitogenic stimulus [20,21]. Among PKC isoforms, the 
isoform has been shown to translocate to the nucleus 
after phorbol ester treatment of NIH 3T3 cells [9] or 
HL-60 cells [22], while the fl isoform seems to reside in 
the nucleus of resting hepatocytes [23]. The coupling of 
DAG generation [5,6] and translocation of a specific 
PKC isoform (i.e. PKC cz) provides a mechanism for 
explaining previously published observations [4,12]. 
Moreover, confocal microscopy resolves the controver- 
sial issue of the actual ocalisation of PKC in the nucleus 
after translocation. Indeed, in combination with the im- 
munocytochemical analysis the in situ confocal sections 
through the equatorial plane of the cells (Fig. 3) indi- 
cated that some GFs (i.e. IGF-I, PDGF and EGF) in- 
duced an accumulation of PKC ~ within the nucleus. 
IGF-I, which activates nuclear PLC fl and increases the 
concentration of nuclear DAG [5,6], gave rise to the 
highest level of translocation. This suggests that DAG 
acts as an attractant for PKC ~ and this finding is 
strengthened by the absence of PKC r~ translocation to 
the nucleus in the cells stimulated with Bombesin, which 
does not induce at all any increase in nuclear DAG levels 
[5]. It will be of interest o study whether or not PDGF 
and EGF can affect nuclear polyphosphoinositide hy- 
drolysis. Our data contribute to an understanding ofhow 
signals originating at the plasma membrane are transmit- 
ted to the nucleus. The steps leading to mitosis are char- 
acterised by an ordered sequence of events which link the 
nuclear inositol ipid cycle to the translocation and acti- 
vation of PKC ~ through the accumulation of nuclear 
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DAG, a well-known physiological activator of this 
isoform [24]. In addition to the phosphorylation of nu- 
clear lamins [25], PKC could also phosphorylate other 
nuclear proteins some of which may be involved in the 
early nuclear events leading to DNA replication. Finally, 
it is interesting that the use of isozyme-specific antisera 
revealed that in Swiss 3T3 cells only PKC 0t occurs in 
both the native and proteolitically-clcaved forms. In- 
deed, it is known that other isoforms (i.e. PKC fl, 7 and 
e) can be cleaved by calpains [2]. Further work will be 
necessary to determine the role of proteolytic leavage 
with respect o PKC 0~ activation and relocalisation to 
cellular compartments. 
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